RxDoctor Payments DataLook up a doctor →

Shireen Guide, MD

Pediatric Dermatology · Palo Alto, CANPI 1033287180

Payments from drug & device makers

$568,893in general payments, 2019–2025

Across 386 payments — averaging $1473.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Krystal Biotech Inc$301K
  • Boehringer Ingelheim$93K
  • Sanofi US Services Inc.$73K
  • Pfizer$47K
  • Boehringer Ingelheim International GmbH$25K
  • Organon$13K
  • plus $17K from 33 others
$41,440in research payments, 2019–2025

Across 20 payments — averaging $2072.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arcutis Biotherapeutics, Inc.$41K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$568,893 in reported general payments places this provider in the 90th percentile of 36 pediatric dermatology providers in California.

See all pediatric dermatology providers in California

Medicare billing

Part B allowed, 2024
$268,173
Medicare patients
304
Services billed
5,156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatric dermatology in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →